Oppenheimer & CO Inc Nevro Corp Transaction History

Oppenheimer & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$141.6 - $179.06 $212,966 - $269,306	-1,504 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$114.09 - $145.51 $171,591 - $218,847	1,504 New	1,504 $210,000
Q4 2017 Feb 07, 2018	SELL	$65.94 - $93.31 $146,386 - $207,148	-2,220 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$80.87 - $91.08 $179,531 - $202,197	2,220	2,220 $202,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.